Background: Postoperative infection is a major complication of spinal surgery with implants. We aimed to identify risk factors for, and characteristics of, postoperative spinal infections in children. Methods: We performed a retrospective observational study of all children who underwent posterior spinal fusion with instrumentation in 2 referral hospitals in [2008][2009][2010][2011][2012][2013]. Spinal infections were defined as local and/or general signs of infection that required surgical treatment in the early postoperative phase (ie, within 30 days). Data were collected on a standardized questionnaire from medical charts. Results: Of the 450 children who underwent spinal surgery, 26 (5.8%) were diagnosed with early postoperative spinal implant infection, with a median age of 14 years (interquartile range, 13-17) and a median delay of 13 days postsurgery (interquartile range, 7-18). Postoperative infection was more common in children with neurologic scoliosis as compared with idiopathic scoliosis (12.2% [15/123] versus 2.4% [5/211]; P < 0.01). Neurologic scoliosis was an independent predictor of spinal implant infections (hazard ratio, 3.87 [1.72-8.69]; P < 0.001). Main pathogens were Staphylococcus aureus (n = 14) and Enterobacteriaceae (n = 8). All children underwent early surgery (wound exploration, debridement and lavage) and antibiotics for a median duration of 19 weeks [interquartile range, 12-26]. Two children (7.7%) required a second surgery. Spinal implants could be retained in all, and no relapse occurred with a follow-up of ≥24 months after antibiotic discontinuation. Conclusions: Postoperative spinal implant infection is not rare in pediatric patients, especially with neurologic scoliosis. Most children may be cured with implant retention if managed with early surgery followed by a 3-month course of appropriate antibacterial agents.
S
pinal deformity in children may require complex surgery, including posterior spinal fusion with instrumentation. Postoperative infection is a major complication of spinal implants, reported in 0.5%-3% of children operated for idiopathic scoliosis and 3.8%-13.3% of children operated for neurologic scoliosis. [1] [2] [3] [4] [5] Although device removal would be desirable to reduce bacterial burden and remove the biofilm, this option is not realistic in early postoperative infections, as it threatens spinal stability. Hence, management relies on early surgery with wound exploration, thorough debridement and lavage, followed by prolonged antibacterial treatment. 3, 6, 7 The optimal duration of antibiotics postdebridement is not defined, and some experts advocate for long-term antimicrobial therapy, 8 although a landmark study in adults found that a 3-month course of antibiotics postdebridement cures most spinal implant infections. 9 We aimed to identify risk factors for early postoperative infections after spinal implantation in children and to characterize these infections, their management and outcomes.
MATERIALS AND METHODS

Study Design
We performed a retrospective, observational study of all children <21-year old who underwent posterior spinal fusion with instrumentation during years 2008-2013 in Rennes and Nantes university hospitals, the referral centers for spinal surgery in children for Western France (population catchment area, 7 million inhabitants). Perioperative antibiotic prophylaxis was administered in all children, 0-60 minutes before skin incision, with cefamandole from 2008 to 2011, or cefazolin in 2012-2013, 50 mg/kg (max 2 g), and was repeated once 4 hours later if the surgery was still ongoing. After surgery, children were routinely followed-up in their referral center during 24 months. Spinal infections were defined as local and/or general signs of infection that required surgical treatment in the early postoperative phase (ie, within 30 days). No written protocol for spinal implant infections in children was available during the study period, but all cases were managed by a multidisciplinary team including pediatric surgeon(s), pediatrician(s), infectious diseases specialist(s) and microbiologist(s).
Data Collection
Children who underwent spinal surgery were identified through review of pediatric surgery operation programs, the "Q-planner." Postoperative infections were identified through (1) department of infection control computerized database, with prospective collection of all postoperative infections since 2007 (mandatory notification); (2) pediatric surgeons registry. Data were collected by 1 investigator (A.L.) on a standardized questionnaire from medical charts, including: demographics, underlying spinal disease, surgery (duration, device implanted, antibiotic prophylaxis), delay between surgery and symptoms onset, between symptoms onset and debridement, microbiology, antibacterial treatment and outcome. All infected patients were followed-up for ≥24 months after antibiotic discontinuation.
Statistics
Continuous variables were expressed as median (interquartile range) and compared using Student t test or Mann-Whitney U test. Categorical variables were expressed as numbers (%) and compared using χ 2 or Fisher exact tests. P < 0.05 was considered statistically significant.
For multivariate analysis, all variables with P < 0.1 by univariate analysis were evaluated using a stepwise logistic regression Table 1) . On multivariate analysis, neuromuscular scoliosis was the only predictor of spinal implant infections (hazard ratio, 3.87 [1.72-8.69]; P < 0.001).
All patients underwent posterior spinal fusion with implantation of spinal titanium rods, various implants (screws, hocks and ligaments) and bone grafts. Median time between initial surgery and symptoms of infection was 13 days [IQR, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Median time between symptoms onset and debridement was 17 days [IQR, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Surgical treatment of postoperative infections consisted of scar incision, wound exploration, debridement and high volume lavage (3-6 L of sterile water with chlorhexidine 0.05%). Spinal implants were retained in all patients. Multiple samples were immediately sent to the laboratory, following principles applied for prosthetic joint infections: (1) ideally, 5 samples from different sites; (2) areas with macroscopic signs of infection to be prioritized and (3) routine cultures to be prolonged 7 days to identify slowgrowing organisms, including coagulase-negative staphylococci and Propionibacterium acnes. Immediately after surgical sampling, high-doses intravenous antistaphylococcal therapy was started in all children (vancomycin or cloxacillin, based on risk factors for methicillin-resistant Staphylococcus aureus), associated with gentamicin or cefotaxime in, respectively, 13 and 12 children.
Microbiologic documentation was obtained in 25 children, including 8 (32%) polymicrobial (Table 2 ). Main pathogens were S. aureus (n = 14, all methicillin-susceptible S. aureus) and Enterobacteriaceae (n = 8, with no isolate resistant to thirdgeneration cephalosporin or fluoroquinolone). Of note, all the patients who developed postoperative Enterobacteriaceae infections (n = 7) had neurologic scoliosis. Only 2 children had positive blood cultures. Twenty-four children underwent oral switch after a median duration of 17 days [IQR, ] with intravenous therapy. Oral therapy was a rifampicin-fluoroquinolone combination in 17 patients (71%). Adverse events requiring treatment alterations were (1) rifampicin-related nausea and vomiting (n = 3), that resolved after dose reduction; (2) ciprofloxacin-related increase in the incidence of seizures in a child with preexisting convulsive encephalopathy that required ciprofloxacin discontinuation. All children were cured, with a follow-up ≥24 months after treatment discontinuation, despite spinal implants were retained in all. Two children with methicillin-susceptible S. aureus infections initially underwent partial surgery with limited incision and incomplete wound exploration: Both required 1 additional surgery with extensive wound exploration, debridement and lavage. Samples taken during the second surgery yielded methicillin-susceptible S. aureus again for 1 child and P. acnes for the other. Both were finally cured with an additional 12 weeks of appropriate antibacterial treatment.
DISCUSSION
The incidence of postoperative spinal implant infections was 5.8% overall in this cohort, in agreement with other studies. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The risk was higher in children with neuromuscular scoliosis, as previously reported. 2, 4 In addition, our study suggests for the first time that spinal implant infections in patients with neuromuscular scoliosis is more likely to be related to Enterobacteriaceae. Indeed, children with neuromuscular lesions, including paraplegia and anal incontinence, may be at increased risk of scar contamination with digestive microbiota, because of the proximity between the lower extremity of the scar (ie, lumbar spine) and the anus. This pathway should be considered for the prevention of postoperative infections in children operated for neuromuscular spinal deformity, with reinforced infection control policy, closer monitoring of surgical scars and early change of wound dressings in case of potential contamination.
Pathogens responsible for postoperative spinal implant infections in this study are in agreement with previous reports, 10 with a predominance of Staphylococcus sp., Enterobacteriaceae, P. acnes and Pseudomonas aeruginosa. Empirical treatment for postoperative spinal infections in our institutions includes piperacillin/tazobactam and gentamicin, which ensures adequate coverage, pending adjustment based on microbiologic documentation and drug susceptibility testing. Optimal duration of antibacterial treatment for spinal implant infections remains unknown, because of the absence of comparative study in the field and the lack of validated surrogate marker for cure that could be used to guide treatment discontinuation. Hence, most experts recommend prolonged antibacterial treatment, at least 3-6 months, although shorter treatment duration may be as effective. In adults, Dubée et al 9 convincingly demonstrated that a 3-month course of antibacterial treatment is sufficient for most patients with early postoperative spinal implant infections. In children, Li et al 8 recommend parenteral antibiotics for a minimum of 4-6 weeks after debridement and lavage with implant retention, followed by oral antibiotics for 2-6 months. The French Society of Infectious Diseases (Société de Pathologie Infectieuse de Langue Française) recommends 2 weeks of intravenous therapy for osteoarticular infections involving foreign devices, relayed by an oral combination during 6-12 weeks. 7 In our study, antibacterial treatment was not protocolized, but most children received either 6, 12 or 24 weeks of antibiotics after debridement and lavage with retention of spinal implants, with a 100% success rate. Of note, more than two-thirds of children received a combination of rifampicin and fluoroquinolone, the preferred regimen for oral step-down in foreign device-related infections when the bacteria involved are susceptible, for the following reasons: (1) fluoroquinolones and rifampicin are among the rare antibiotics with bactericidal activity on biofilm; (2) both penetrate well in bone tissues; (3) digestive absorption is excellent, so that oral administration is similar to intravenous in terms of plasma concentration. The 2 children who required 1 additional surgical treatment for infection were those who underwent only partial surgery initially. These findings suggest that antibacterial treatment can be safely discontinued 3 months after surgical treatment of spinal implant infections, provided wound exploration, debridement and lavage, were rigorously performed. This is in line with current guidelines for the management of prosthetic joint infections in adults, with the "Debridement, Antibiotics, and Implant Retention" approach, with cure rates >90% provided surgical intervention was performed early (ie, <3 weeks) after infection onset. Although this recommendation is a significant step forward as compared with current recommendations of 4-6 weeks intravenous, followed by 2-6 months oral antibiotics in children, 8 this may still be quite conservative, as no failure was reported among the 4 children who received only 6 weeks postoperatively in our series.
This observational study has limitations. First, data were collected retrospectively from medical charts, hence important information may be lost. Second, sample size was limited (although among the largest reported to date). Third, management was not protocolized during the study period, with significant heterogeneity between the 2 sites. However, this study adds significant information on risk factors for, characteristics of this major postoperative infection and may contribute to reduce antibacterial treatment duration, given the 100% cure rates observed after adequate debridement and lavage with implant retention, followed by 6-12 weeks of antibiotics. 
